合計 50 件の最近のインサイダー取引記録が記録されています Astria Therapeutics, Inc. (ATXS), 内訳は 45 件の買い および 4 件の売り. インサイダー買い総額は $85.92M インサイダー売り総額は $1.05M.
最近活動のある主要インサイダーには Kishbauch Michael D, Bate Kenneth, Lapointe Anthony Gregg. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ATXS
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-06-11 |
Kishbauch Michael D |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Bate Kenneth |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Lapointe Anthony Gregg |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Cole Hugh M |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Agarwal Sunil |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Violin Jonathan |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Beck Joanne T. |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-06-11 |
Callori Fred |
Director |
RSU 付与（制限付株式） |
26,550 |
$5.79 |
$153.72K |
26,550 |
| 2025-03-21 |
Milne Jill C. |
CEO and President |
RSU 付与（制限付株式） |
761,000 |
$6.41 |
$4.88M |
761,000 |
| 2025-03-21 |
Harshbarger Benjamin |
Chief Legal Officer |
RSU 付与（制限付株式） |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2025-03-21 |
Komjathy Andrew |
Chief Commercial Officer |
RSU 付与（制限付株式） |
225,000 |
$6.41 |
$1.44M |
225,000 |
| 2025-03-21 |
Clauser Noah |
Chief Financial Officer |
RSU 付与（制限付株式） |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2025-03-21 |
Morabito Christopher |
Chief Medical Officer |
RSU 付与（制限付株式） |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2025-03-21 |
Matthews Andrea |
Chief Business Officer |
RSU 付与（制限付株式） |
262,500 |
$6.41 |
$1.68M |
262,500 |
| 2024-06-05 |
Kishbauch Michael D |
Director |
RSU 付与（制限付株式） |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Bate Kenneth |
Director |
RSU 付与（制限付株式） |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Lapointe Anthony Gregg |
Director |
RSU 付与（制限付株式） |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Cole Hugh M |
Director |
RSU 付与（制限付株式） |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Violin Jonathan |
Director |
RSU 付与（制限付株式） |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Beck Joanne T. |
Director |
RSU 付与（制限付株式） |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-06-05 |
Callori Fred |
Director |
RSU 付与（制限付株式） |
14,100 |
$9.18 |
$129.44K |
14,100 |
| 2024-04-08 |
Agarwal Sunil |
Director |
RSU 付与（制限付株式） |
28,200 |
$11.40 |
$321.48K |
28,200 |
| 2024-04-05 |
Agarwal Sunil |
Director |
不明 |
- |
- |
- |
- |
| 2024-04-01 |
Morabito Christopher |
Chief Medical Officer |
情報に基づく売り |
10,000 |
$13.59 |
$135.94K |
- |
| 2024-02-08 |
Milne Jill C. |
CEO and President |
RSU 付与（制限付株式） |
534,600 |
$15.26 |
$8.16M |
534,600 |
| 2024-02-08 |
Harshbarger Benjamin |
Chief Legal Officer |
RSU 付与（制限付株式） |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Komjathy Andrew |
Chief Commercial Officer |
RSU 付与（制限付株式） |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Clauser Noah |
Chief Financial Officer |
RSU 付与（制限付株式） |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Morabito Christopher |
Chief Medical Officer |
RSU 付与（制限付株式） |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-08 |
Matthews Andrea |
Chief Business Officer |
RSU 付与（制限付株式） |
175,000 |
$15.26 |
$2.67M |
175,000 |
| 2024-02-01 |
Perceptive Advisors Llc |
Director |
情報に基づく買い |
2,481,350 |
$12.09 |
$30M |
4,873,721 |
| 2024-01-29 |
Morabito Christopher |
Chief Medical Officer |
情報に基づく売り |
9,200 |
$11.15 |
$102.55K |
- |
| 2024-01-26 |
Morabito Christopher |
Chief Medical Officer |
情報に基づく売り |
800 |
$11.02 |
$8.81K |
- |
| 2023-12-21 |
Perceptive Advisors Llc |
Director |
情報に基づく買い |
740,000 |
$6.20 |
$4.59M |
2,392,371 |
| 2023-10-16 |
Perceptive Advisors Llc |
Director |
情報に基づく買い |
460,546 |
$8.03 |
$3.7M |
345,409 |
| 2023-06-02 |
Kishbauch Michael D |
Director |
RSU 付与（制限付株式） |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Bate Kenneth |
Director |
RSU 付与（制限付株式） |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Lapointe Anthony Gregg |
Director |
RSU 付与（制限付株式） |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Cole Hugh M |
Director |
RSU 付与（制限付株式） |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Milne Jill C. |
CEO and President |
RSU 付与（制限付株式） |
275,000 |
$13.36 |
$3.67M |
275,000 |
| 2023-06-02 |
Harshbarger Benjamin |
Chief Legal Officer |
RSU 付与（制限付株式） |
90,000 |
$13.36 |
$1.2M |
90,000 |
| 2023-06-02 |
Violin Jonathan |
Director |
RSU 付与（制限付株式） |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Beck Joanne T. |
Director |
RSU 付与（制限付株式） |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Komjathy Andrew |
Chief Commercial Officer |
RSU 付与（制限付株式） |
80,000 |
$13.36 |
$1.07M |
80,000 |
| 2023-06-02 |
Clauser Noah |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
$13.36 |
$1.34M |
100,000 |
| 2023-06-02 |
Callori Fred |
Director |
RSU 付与（制限付株式） |
14,100 |
$11.35 |
$160.04K |
14,100 |
| 2023-06-02 |
Morabito Christopher |
Chief Medical Officer |
RSU 付与（制限付株式） |
90,000 |
$13.36 |
$1.2M |
90,000 |
| 2023-06-02 |
Matthews Andrea |
Chief Business Officer |
RSU 付与（制限付株式） |
60,000 |
$13.36 |
$801.6K |
60,000 |
| 2023-04-17 |
Matthews Andrea |
Chief Business Officer |
処分 |
60,000 |
$13.36 |
$801.6K |
- |
| 2023-04-17 |
Matthews Andrea |
Chief Business Officer |
RSU 付与（制限付株式） |
20,000 |
$10.82 |
$216.4K |
20,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
